Listen to the audio version of this article (generated by AI).
Listen to the audio version of this article (generated by AI).
His successor will be announced shortly.
Smith has led the Hungarian organization for two years, focusing on access to innovative medicines and vaccines, patient-centered healthcare and cooperation across the healthcare sector.
During his tenure, he promoted clinical research, prevention, scientific excellence and data-driven decision-making. He also supported collaboration between Hungarian biotechnology companies, academic projects and the pharmaceutical industry, exploring how locally developed innovations could help address global challenges.
MSD said Smith’s leadership had made a lasting contribution to its Hungarian operations and external partnerships. The company reaffirmed its commitment to Hungary and continued cooperation with the healthcare community to improve patient outcomes and support the development of a future-ready healthcare system.
The company did not disclose further details of Smith’s new global position.
Producing journalism that is worthy of the name is a costly business. For over 30 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.
